<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Health Technology Collaboration | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/digital-pathology-news/health-technology-collaboration/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Tue, 20 Oct 2026 12:52:38 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Health Technology Collaboration | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>HistoIndex and A*STAR Partner To Advance Early – Stage Development Of Pipeline Therapies For Fibrotic Diseases</title>
		<link>https://tissuepathology.com/2026/10/20/histoindex-and-astar-partner-to-advance-early-stage-development-of-pipeline-therapies-for-fibrotic-diseases/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 20 Oct 2026 12:52:38 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[A*STAR]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[cancer-associated fibrosis]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Fibrotic Diseases]]></category>
		<category><![CDATA[Histoindex]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[research and development]]></category>
		<category><![CDATA[Singapore]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24747</guid>

					<description><![CDATA[<p>[SINGAPORE, October 19th, 2026] – /PR Newswire/ HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector R&#38;D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the preclinical evaluation and characterization of therapeutic candidates for various fibrotic diseases, including [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/10/20/histoindex-and-astar-partner-to-advance-early-stage-development-of-pipeline-therapies-for-fibrotic-diseases/">HistoIndex and A*STAR Partner To Advance Early – Stage Development Of Pipeline Therapies For Fibrotic Diseases</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership</title>
		<link>https://tissuepathology.com/2026/10/16/indica-labs-and-neogenomics-expand-ai-leadership-through-enterprise-digital-pathology-partnership/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 16 Oct 2026 11:41:44 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24740</guid>

					<description><![CDATA[<p>ALBUQUERQUE, N.M, October 15, 2026 — Indica Labs, the trusted global leader in AI-powered digital pathology, today announced a significant expansion of its strategic partnership with NeoGenomics, a leading provider of oncology diagnostic solutions that enable precision medicine. The expanded collaboration is intended to modernize NeoGenomics enterprise digital pathology infrastructure, accelerate the evaluation and adoption [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/10/16/indica-labs-and-neogenomics-expand-ai-leadership-through-enterprise-digital-pathology-partnership/">Indica Labs and NeoGenomics Expand AI Leadership Through Enterprise Digital Pathology Partnership</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research</title>
		<link>https://tissuepathology.com/2026/10/12/lunit-and-discovery-life-sciences-collaborate-to-expand-ai-powered-tissue-analysis-for-biopharma-research/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 12 Oct 2026 13:40:49 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Biopharma]]></category>
		<category><![CDATA[Collaboration]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Discovery Life Sciences]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Lunit]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[tissue analysis]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24731</guid>

					<description><![CDATA[<p>Lunit and Discovery Life Sciences: Collaboration expands access to Lunit&#8217;s AI-powered pathology platform by combining it with Discovery Life Sciences&#8217; global biospecimen and specialty laboratory capabilities, enabling standardized tissue insights for biomarker research and drug development. SEOUL, South Korea, Oct. 12, 2026 /PRNewswire/ &#8212; Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/10/12/lunit-and-discovery-life-sciences-collaborate-to-expand-ai-powered-tissue-analysis-for-biopharma-research/">Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients</title>
		<link>https://tissuepathology.com/2026/09/29/leica-biosystems-completes-acquisition-of-statlab-to-bolster-delivery-of-more-precise-timely-diagnostics-for-cancer-patients/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 29 Sep 2026 12:00:21 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[leica biosystems]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Stat Lab]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24706</guid>

					<description><![CDATA[<p>Acquisition advances Leica Biosystems&#8217; end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them DEER PARK, Ill., Sept. 28, 2026 /PRNewswire/ &#8212; Leica Biosystems, a Danaher company (the &#8220;Company&#8221;) and a global leader in digital and anatomic [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/29/leica-biosystems-completes-acquisition-of-statlab-to-bolster-delivery-of-more-precise-timely-diagnostics-for-cancer-patients/">Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proscia: How Unilabs is Advancing Digital Pathology and Precision Medicine with Proscia</title>
		<link>https://tissuepathology.com/2026/09/25/proscia-how-unilabs-is-advancing-digital-pathology-and-precision-medicine-with-proscia/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 25 Sep 2026 15:11:45 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Blogs]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[Proscia]]></category>
		<category><![CDATA[Unilabs]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24702</guid>

					<description><![CDATA[<p>From the Proscia blog: Every patient’s care journey starts with a diagnosis. As our understanding of disease becomes more nuanced, pathologists are expected to deliver increasingly specific answers. Meanwhile, their expertise is in short supply, and demand for diagnostic services continues to rise. Many laboratories are finding it harder to consistently provide the timely, informed [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/25/proscia-how-unilabs-is-advancing-digital-pathology-and-precision-medicine-with-proscia/">Proscia: How Unilabs is Advancing Digital Pathology and Precision Medicine with Proscia</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Voicebrook Announces Digital Pathology Integration with Indica Labs, Delivering Automated AI Biomarker Reporting and Hands-Free Navigation</title>
		<link>https://tissuepathology.com/2026/09/23/voicebrook-announces-digital-pathology-integration-with-indica-labs-delivering-automated-ai-biomarker-reporting-and-hands-free-navigation/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 23 Sep 2026 11:59:22 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Biomarker Reporting]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Hands-Free Navigation]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Indica Labs]]></category>
		<category><![CDATA[Integration]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[voicebrook]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24697</guid>

					<description><![CDATA[<p>Roslyn Heights, NY,  Albuquerque, NM, September 22, 2026 – Voicebrook, the leader in pathology workflow automation, driving reporting end to end, today announced a new integration partnership with Indica Labs, the trusted global leader in AI-powered digital pathology. The integration connects Voicebrook’s VoiceOver PRO reporting workflow to the Indica Labs HALO AP® platform, giving pathologists hands-free [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/23/voicebrook-announces-digital-pathology-integration-with-indica-labs-delivering-automated-ai-biomarker-reporting-and-hands-free-navigation/">Voicebrook Announces Digital Pathology Integration with Indica Labs, Delivering Automated AI Biomarker Reporting and Hands-Free Navigation</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
